Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Elisabeth Specht Stovgaard"'
Autor:
Bálint Cserni, Darren Kilmartin, Mark O’Loughlin, Xavier Andreu, Zsuzsanna Bagó-Horváth, Simonetta Bianchi, Ewa Chmielik, Paulo Figueiredo, Giuseppe Floris, Maria Pia Foschini, Anikó Kovács, Päivi Heikkilä, Janina Kulka, Anne-Vibeke Laenkholm, Inta Liepniece-Karele, Caterina Marchiò, Elena Provenzano, Peter Regitnig, Angelika Reiner, Aleš Ryška, Anna Sapino, Elisabeth Specht Stovgaard, Cecily Quinn, Vasiliki Zolota, Mark Webber, Sharon A. Glynn, Rita Bori, Erika Csörgő, Orsolya Oláh-Németh, Tamás Pancsa, Anita Sejben, István Sejben, András Vörös, Tamás Zombori, Tibor Nyári, Grace Callagy, Gábor Cserni
Publikováno v:
Cancers, Vol 15, Iss 4, p 1199 (2023)
Tumour-infiltrating lymphocytes (TILs) reflect antitumour immunity. Their evaluation of histopathology specimens is influenced by several factors and is subject to issues of reproducibility. ONEST (Observers Needed to Evaluate Subjective Tests) helps
Externí odkaz:
https://doaj.org/article/b5737028920b4e1fa44a2db009fed358
Autor:
Elahe Shenasa, Elisabeth Specht Stovgaard, Maj-Britt Jensen, Karama Asleh, Nazia Riaz, Dongxia Gao, Samuel Leung, Bent Ejlertsen, Anne-Vibeke Laenkholm, Torsten O. Nielsen
Publikováno v:
Cancers, Vol 14, Iss 15, p 3808 (2022)
Recent studies have shown that immune infiltrates in the tumor microenvironment play a role in response to therapy, with some suggesting that patients with immunogenic tumors may receive increased benefit from chemotherapies. We evaluated this hypoth
Externí odkaz:
https://doaj.org/article/dd93e053fcf840fabc7dc7406fba4885
Autor:
Darren Kilmartin, Mark O’Loughlin, Xavier Andreu, Zsuzsanna Bagó-Horváth, Simonetta Bianchi, Ewa Chmielik, Gábor Cserni, Paulo Figueiredo, Giuseppe Floris, Maria Pia Foschini, Anikó Kovács, Päivi Heikkilä, Janina Kulka, Anne-Vibeke Laenkholm, Inta Liepniece-Karele, Caterina Marchiò, Elena Provenzano, Peter Regitnig, Angelika Reiner, Aleš Ryška, Anna Sapino, Elisabeth Specht Stovgaard, Cecily Quinn, Vasiliki Zolota, Mark Webber, Davood Roshan, Sharon A. Glynn, Grace Callagy
Publikováno v:
Cancers, Vol 13, Iss 17, p 4410 (2021)
Stromal tumour infiltrating lymphocytes (sTILs) are a strong prognostic marker in triple negative breast cancer (TNBC). Consistency scoring sTILs is good and was excellent when an internet-based scoring aid developed by the TIL-WG was used to score c
Externí odkaz:
https://doaj.org/article/000cc0d867314f44ae8d89acc4df4feb
Autor:
Jeppe Thagaard, Elisabeth Specht Stovgaard, Line Grove Vognsen, Søren Hauberg, Anders Dahl, Thomas Ebstrup, Johan Doré, Rikke Egede Vincentz, Rikke Karlin Jepsen, Anne Roslind, Iben Kümler, Dorte Nielsen, Eva Balslev
Publikováno v:
Cancers, Vol 13, Iss 12, p 3050 (2021)
Triple-negative breast cancer (TNBC) is an aggressive and difficult-to-treat cancer type that represents approximately 15% of all breast cancers. Recently, stromal tumor-infiltrating lymphocytes (sTIL) resurfaced as a strong prognostic biomarker for
Externí odkaz:
https://doaj.org/article/30e244141f494b9c91ca7436908cfb23
Autor:
Elisabeth Specht Stovgaard, Ib Jarle Christensen, Kamille List-jensen, Eva Balslev, Dorte Nielsen, Iben Kümler, Estrid Høgdall, Anne Roslind
Publikováno v:
Applied Immunohistochemistry & Molecular Morphology. 30:62-71
The immune checkpoint molecule lymphocyte activation gene 3 (LAG-3) is currently being investigated as a possible target for immunotherapy in triple-negative breast cancer (TNBC), frequently as an addition to treatment with programmed cell death prot
Autor:
Anne Roslind, K List-Jensen, Dorte Nielsen, Elisabeth Specht Stovgaard, Eva Balslev, Estrid Høgdall, M Bokharaey, Iben Kümler
Publikováno v:
Breast Cancer Research and Treatment. 181:553-560
PD-L1 expression is a predictive biomarker for anti-PD-L1 immunotherapy in triple negative breast cancer (TNBC). In the neoadjuvant setting, immunohistochemical (IHC) evaluation of PD-L1 expression can only be performed on small tissue biopsies. In o
Autor:
Elisabeth Specht Stovgaard, Dorte Nielsen, Troels Dreier Christensen, Eva Balslev, Sofie S. Jespersen, Ib Jarle Christensen, Anna Sofie Kappel Buhl
Publikováno v:
Applied Immunohistochemistry & Molecular Morphology. 29:e5-e9
Secreted phospholipase A2 group IIa (sPLA2-IIa) has been shown to promote tumor genesis and cell proliferation. The properties of this group of enzymes are utilized in liposomal drug delivery of chemotherapy. sPLA2-IIa is also under investigation as
Autor:
Elena Provenzano, Päivi Heikkilä, Elisabeth Specht Stovgaard, Gábor Cserni, Sharon A. Glynn, Inta Liepniece-Karele, Simonetta Bianchi, Xavier Andreu, Janina Kulka, Mark O’Loughlin, Caterina Marchiò, Davood Roshan, Maria Pia Foschini, Mark Webber, Zsuzsanna Bago-Horvath, Anna Sapino, Grace Callagy, Peter Regitnig, Giuseppe Floris, Ewa Chmielik, Ales Ryska, Anikó Kovács, Cecily Quinn, Angelika Reiner, Vasiliki Zolota, Darren Kilmartin, Anne Vibeke Lænkholm, Paulo Figueiredo
Publikováno v:
Cancers
Volume 13
Issue 17
Kilmartin, D, O’Loughlin, M, Andreu, X, Bagó-Horváth, Z, Bianchi, S, Chmielik, E, Cserni, G, Figueiredo, P, Floris, G, Foschini, M P, Kovács, A, Heikkilä, P, Kulka, J, Laenkholm, A V, Liepniece-Karele, I, Marchiò, C, Provenzano, E, Regitnig, P, Reiner, A, Ryška, A, Sapino, A, Stovgaard, E S, Quinn, C, Zolota, V, Webber, M, Roshan, D, Glynn, S A & Callagy, G 2021, ' Intra-tumour heterogeneity is one of the main sources of inter-observer variation in scoring stromal tumour infiltrating lymphocytes in triple negative breast cancer ', Cancers, vol. 13, no. 17, 4410 . https://doi.org/10.3390/cancers13174410
Cancers, Vol 13, Iss 4410, p 4410 (2021)
Volume 13
Issue 17
Kilmartin, D, O’Loughlin, M, Andreu, X, Bagó-Horváth, Z, Bianchi, S, Chmielik, E, Cserni, G, Figueiredo, P, Floris, G, Foschini, M P, Kovács, A, Heikkilä, P, Kulka, J, Laenkholm, A V, Liepniece-Karele, I, Marchiò, C, Provenzano, E, Regitnig, P, Reiner, A, Ryška, A, Sapino, A, Stovgaard, E S, Quinn, C, Zolota, V, Webber, M, Roshan, D, Glynn, S A & Callagy, G 2021, ' Intra-tumour heterogeneity is one of the main sources of inter-observer variation in scoring stromal tumour infiltrating lymphocytes in triple negative breast cancer ', Cancers, vol. 13, no. 17, 4410 . https://doi.org/10.3390/cancers13174410
Cancers, Vol 13, Iss 4410, p 4410 (2021)
Stromal tumour infiltrating lymphocytes (sTILs) are a strong prognostic marker in triple negative breast cancer (TNBC). Consistency scoring sTILs is good and was excellent when an internet-based scoring aid developed by the TIL-WG was used to score c
Autor:
Thomas Ebstrup, Søren Hauberg, Johan Doré, Jeppe Thagaard, Elisabeth Specht Stovgaard, Anne Roslind, Eva Balslev, Line Grove Vognsen, Rikke Egede Vincentz, Iben Kümler, Anders Bjorholm Dahl, Rikke Karlin Jepsen, Dorte Nielsen
Publikováno v:
Cancers
Thagaard, J, Stovgaard, E S, Vognsen, L G, Hauberg, S, Dahl, A, Ebstrup, T, Doré, J, Vincentz, R E, Jepsen, R K, Roslind, A, Kümler, I, Nielsen, D & Balslev, E 2021, ' Automated quantification of stil density with h &e-based digital image analysis has prognostic potential in triple-negative breast cancers ', Cancers, vol. 13, no. 12, 3050 . https://doi.org/10.3390/cancers13123050
Cancers, Vol 13, Iss 3050, p 3050 (2021)
Thagaard, J, Stovgaard, E S, Vognsen, L G, Hauberg, S, Dahl, A, Ebstrup, T, Doré, J, Vincentz, R E, Jepsen, R K, Roslind, A, Kümler, I, Nielsen, D & Balslev, E 2021, ' Automated quantification of stil density with h &e-based digital image analysis has prognostic potential in triple-negative breast cancers ', Cancers, vol. 13, no. 12, 3050 . https://doi.org/10.3390/cancers13123050
Cancers, Vol 13, Iss 3050, p 3050 (2021)
Simple Summary Around 15% of breast cancer patients are diagnosed as triple-negative (TNBC), which have significantly lower 5-year survival rates (77%) than other types of breast cancer (93%). Our study aimed at developing an image analysis-based bio
Autor:
Karama Asleh, Elisabeth Specht Stovgaard, Torsten O. Nielsen, Samuel Leung, Nazia Riaz, Eva Balslev, Maj-Britt Jensen, Lise B. Nielsen, Dongxia Gao, Dorte Nielsen, Anne Vibeke Lænkholm
Publikováno v:
Oncoimmunology
article-version (VoR) Version of Record
Stovgaard, E S, Asleh, K, Riaz, N, Leung, S, Gao, D, Nielsen, L B, Lænkholm, A V, Balslev, E, Jensen, M B, Nielsen, D & O Nielsen, T 2021, ' The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine ', OncoImmunology, vol. 10, no. 1, 1924492 . https://doi.org/10.1080/2162402X.2021.1924492
OncoImmunology, Vol 10, Iss 1 (2021)
article-version (VoR) Version of Record
Stovgaard, E S, Asleh, K, Riaz, N, Leung, S, Gao, D, Nielsen, L B, Lænkholm, A V, Balslev, E, Jensen, M B, Nielsen, D & O Nielsen, T 2021, ' The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine ', OncoImmunology, vol. 10, no. 1, 1924492 . https://doi.org/10.1080/2162402X.2021.1924492
OncoImmunology, Vol 10, Iss 1 (2021)
Preclinical studies suggest that some effects of conventional chemotherapy, and in particular, gemcitabine, are mediated through enhanced antitumor immune responses. The objective of this study was to use material from a randomized clinical trial to